Vir Biotechnology (VIR) Cash from Financing (Quarterly): 78.38M

Vir Biotechnology, Inc. (VIR)

11.70 +0.58 (+5.22%) USD | NASDAQ | Oct 09, 16:00

11.70 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Start Trial.

Date	Value
June 30, 2026	78.38M
March 31, 2026	162.52M
December 31, 2025	1.039M
September 30, 2025	0.102M
June 30, 2025	2.046M
March 31, 2025	0.598M
December 31, 2024	1.263M
September 30, 2024	0.031M
June 30, 2024	2.942M
March 31, 2024	0.152M
December 31, 2023	1.68M
September 30, 2023	0.277M
June 30, 2023	3.179M
March 31, 2023	2.244M
December 31, 2022	2.011M
September 30, 2022	1.985M

Date	Value
June 30, 2022	3.08M
March 31, 2022	27.68M
December 31, 2021	5.67M
September 30, 2021	3.629M
June 30, 2021	3.529M
March 31, 2021	87.50M
December 31, 2020	-0.259M
September 30, 2020	324.31M
June 30, 2020	205.34M
March 31, 2020	0.085M
December 31, 2019	130.10M
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018	10.44M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks